Psychedelic stocks have exploded on news of the Compass Pathways IPO. Three companies are leading the charge.
Why Is Kevin O’Leary So Bullish On Psychedelics?
Kevin O’Leary won’t touch cannabis as an investment but he loves the potential of psychedelic drugs. Why?
Petition Pushes for National Medical Cannabis Insurance For Canadians
A new healthcare technology company, Cannalogue, is launching a petition in their native land of Canada to get the Ministries of Health on board with providing national healthcare coverage for medical cannabis.
Sweeping Expungement Bill Passed By Michigan Senate
The Michigan Senate has approved legislation that would automatically expunge thousands of criminal records for low-level crimes and even some felonies.
Marijuana Businesses Could Get Federal Disaster Relief Funds Under New Congressional Bill
Marijuana businesses impacted by recent natural disasters or that have experienced financial distress due to the coronavirus pandemic would be eligible for federal relief programs under new legislation introduced in the House of Representatives and Senate on Thursday.
Mindleap Health Announces The Launch of The World’s First Telehealth Platform For Psychedelic Integration
Mydecine Innovation's Mindleap subsidary launches a telehealth platform for psychedelics.
Vermont finally OKs retail cannabis stores, years after legalizing
Nearly two years after legalizing the possession of marijuana for all adults, the Vermont legislature yesterday passed a bill that will finally allow the state’s first licensed retail cannabis stores to open no later than May 1, 2022.
New FDA Guidance Will Make It Easier To Approve CBD-Based Medicines
The Food and Drug Administration (FDA) is releasing new draft guidelines that are meant to streamline approvals for generic oral CBD medications.
Illinois Cannabis Sales to Non-Residents Booming
Illinois cannabis sales to out-of-state residents have nearly doubled since sales began in January from $8.6 million to $17.2 million in August, the Center Square reports.
Why Are Silicon Valley Billionaires Unicorn-Hunting In Psychedelics?
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory
Numinus starts psilocybon cultivation operations in its 7,000 sq ft Health Canada-licensed facility.
Why Is Silicon Valley Unicorn-Hunting In Big Pharma's Backyard?
Move over Big Pharma, Here Comes Silicon Valley Investment In Psychedelics Stocks Like Compass Pathways (CMPS)
